Innovation for Health - 13 February 2020
Contact Investor Forum I4H Bootcamp
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare

Nicolas Vergauwe

CEO, miDIAGNOSTICS

Session

11:30 - 12:45
Precision Medicine

Nicolas is a BioScience Engineer by training holding a PhD in microfluidics and diagnostics. He has a broad interest and experience in the domains of qPCR, next-generation sequencing, immunoassays and data analytics, and a passion for transitioning novel technologies into high-impact diagnostics that improve clinical decision taking for the patient's benefit in various diagnostics fields like oncology and infectious diseases.

Nicolas joined miDIAGNOSTICS as CEO in April 2018. In this capacity, Nicolas and his team will develop and extend the miDIAGNOSTICS product portfolio by building further on the groundbreaking research of Imec and Johns Hopkins University. Until March 2018, Nicolas was Vice President Innovations at Biocartis, a molecular diagnostics company that has developed a sample-to-result platform for oncology and infectious disease applications. As VIP Innovations, Nicolas was responsible for bringing novel technologies and assay concepts to the market.

Beyond the limitations of point-of-care testing: opportunities for a new platform concept

Point-of-care testing holds great promise to improve the disease management of patients since these tests can be used in close proximity to the patient. This facilitates the decision-taking process by the physician as test results can be delivered within the time frame of the physician-patient interaction. Unfortunately, in most cases, point-of-care tests provide only a partial answer while the quality is not on par with standard comprehensive testing performed in the lab. miDiagnostics is developing a novel point-of-care testing platform that goes beyond these limitations driven by a series of breakthroughs in semiconductor technologies and nanofluidic engineering.
Marcel Levi
University College London Hospitals
Annemarie Jorritsma
NVP
Rajiv Vaid Basaiawmoit
Aarhus University & Biosymfonix

Claudia Rijcken
pharmi

Inge Huitinga
Netherlands Brain Bank
Wiro Niessen
Erasmus MC, TU Delft & Quantib
Els Beirnaert
Aelin Therapeutics
Joep Muijrers
PureTech Health
Koenraad Wiedhaup
McKinsey & Company
Esther Talboom-Kamp
Saltro Diagnostics
Elise Meijer
Antwerp Management School & Accenture Strategy
Carine van den Brink
Axon Lawyers
Tim Knotnerus
AgomAb Therapeutics
Sjaak Vink
TheSocialMedwork
Hans Schikan
Topsector Life Sciences & Health
Thijn Brummelkamp
Scenic Biotech
Nadine Rouleaux
Maastricht University
Dharminder Chahal
SkylineDx, Van Herk Investsments, Swanbridge

Marianne van der Steen
RegMedXB & Maastricht University

Sponsors & Partners 2020
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Platinum sponsor
Gold sponsor
Silver sponsor
Silver sponsor
Programme Sponsor AI
Award sponsor
AXON Lawyers
Media sponsor
Powered by
Hyphen Projects
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.